Materials will be made available on the Resources page of the Praxis website following presentation at AAN 2025: https://praxismedicines.com/resources/. About ...

Neurology biotech Voyager Therapeutics has laid off 30 employees, a spokesperson for the Massachusetts-based company ...

Kodiak (KOD) is a clinical phase biotech focused on retinal diseases, with a compact, but promising late-stage pipeline. The company currently has three molecules in late stage clinical trials, ...

Novo Nordisk is winding down a range of early-stage programs for liver disease, oncology and stem cells as part of the Danish Pharma’s ambitious restructuring. This morning’s third-quarter earnings ...

AGOURA HILLS, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) ("OTLC" or the "Company"), a clinical-stage ...

Ian Mortimer, President and CEO, highlighted three critical priorities: completion of the Phase III X-TOLE2 study of azetukalner for focal onset seizures with top line data readout in early 2026; ...

Restructuring pipeline to focus on AAV cardiovascular platform (Danon disease, PKP2-ACM, BAG3-DCM) and regulatory activities for KRESLADI™ (severe LAD-I), setting foundation for near- and long-term ...

Roivant Sciences Ltd. (NASDAQ: ROIV) set out its long-term vision on Tuesday during its Investor Day, outlining accelerated timelines and expanded commercial ambitions across several late-stage ...

This is read by an automated voice. Please report any issues or inconsistencies here. San Diego-based Avidity Biosciences Inc. agreed to be acquired by Novartis AG in a deal valued at $12 billion.

For many new business owners, understanding how money moves through their company can feel overwhelming. While passion and skill often drive people to start a business, practical financial knowledge ...